Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
13641
NTS_QECH
Published 2022“…Estimated minimum incidence of iNTS disease decreased from 21/100,000 per year in 2011 to 7/100,000 per year in 2019. …”
-
13642
Table_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13643
Table_3_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.xlsx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13644
Table_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13645
DataSheet_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13646
Table_2_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.xlsx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13647
Table_3_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.xlsx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13648
DataSheet_1_Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types.docx
Published 2023“…Dupilumab has emerged as an alternative option for BP patients.</p>Objective<p>We evaluated the efficiency and safety of dupilumab on BP treatment and explored a mode of drug action in depth.…”
-
13649
Data Sheet 1_Neutrophil extracellular traps and macrophage activation contibute to thrombosis and post-covid syndrome in SARS-CoV-2 infection.pdf
Published 2025“…NETs markers (myeloperoxidase (MPO), neutrophil elastase (NE), p-selectin (P-SEL) and S100A8/S100A9 heterodimer (MRP)) and macrophage activation markers (Chitotriosidase activity (ChT), CCL18/PARC and YKL-40) were measured.…”
-
13650
Effect of broad-spectrum potassium channel blockers on evoked DA overflow.
Published 2013“…(E) After a 30 min application of 100 µM 4-AP, 1 µM ConoTX was applied and caused a ∼ 90% decrease in evoked DA release. …”
-
13651
Effect of the overexpression of Mfn2 or the truncated Mfn2 mutant on mitochondrial function in GCDCA-treated L02 cells.
Published 2013“…The results are expressed as a percentage of the control value, which was set at 100%. …”
-
13652
Data Sheet 2_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf
Published 2025“…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
-
13653
Data Sheet 4_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf
Published 2025“…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
-
13654
Data Sheet 3_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf
Published 2025“…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
-
13655
Data Sheet 5_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf
Published 2025“…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
-
13656
Data Sheet 1_Characterization and immunoprotection of thioredoxin reductase TrxB knockout mutant of Salmonella Enteritidis.pdf
Published 2025“…We also observed a significant decrease in the expression of virulence-related genes in the trxB-knockout mutant. …”
-
13657
Effects of hormone therapy and high-fat diet on microglia in female mice.
Published 2017“…Scale bar in (A) measure 20 μm and in (D) measures 100 μm.</p>…”
-
13658
No expression of eMHC in RFs and attenuation of ongoing muscle regeneration in aged <i>mdx</i> and <i>mdx52</i> mice.
Published 2013“…Values are mean ± S.D. (<i>n</i> = 3–6 mice per group). A significant decrease in the number of eMHC-positive fibers is found only at 18<b> </b>months old in <i>mdx</i> mice (**<i>P</i><0.01 compared to 2<b> </b>months old, †<i>P</i><0.05 compared to 6 and 12<b> </b>months old). …”
-
13659
Effects of Gu-4 on survival and expression profiles of TNF-α and IL-10 in septic mice.
Published 2013“…Gu-4 administration significantly reduced LPS-induced mortality at the doses of 0.88, 1.06, 1.27 and 1.53 mg/kg. *: p<0.05 indicates a significant decrease in mortality by Gu-4 treatment versus saline treatment as determined by log-rank test. β-lactose or dexamethasone (Dex) did not produce significant improvement in survival. …”
-
13660
Cartilage and subchondral bone degeneration scores at 7 and 12 wks after the start of the experiment.
Published 2023“…<p><b>A:</b> a, b and c; Representative toluidine blue staining of each group at 7 wks after the start of experiment. …”